Welcome to our dedicated page for Trupanion SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trupanion, Inc. filings document the company’s pet medical insurance business, public-company governance, and capital structure. Form 8-K reports include quarterly and annual operating results, with disclosures on subscription revenue, enrolled pets, net acquisition cost, adjusted EBITDA, operating cash flow, and other measures used to describe the company’s insurance economics.
The filing record also covers material agreements, including credit facilities, secured borrowings, maturity terms, covenants, and limits on corporate actions. Proxy materials document director elections, board composition, executive compensation, equity awards, shareholder voting matters, and related governance disclosures.
TRUPANION, INC. director Bradley S. Powell reported an automatic equity compensation event. On May 22, 2026, 639 restricted stock units vested and converted into 639 shares of common stock at $0.00 per share under a previously granted RSU award.
The filing shows this as an exercise or conversion of a derivative security, not an open-market purchase or sale. Following the conversion, Powell directly holds 1,906 shares of Trupanion common stock. The RSUs convert into common stock on a one-for-one basis and were part of a 1,906-unit grant from November 14, 2025 that vested in three equal installments.
TRUPANION, INC. director Howard E. Rubin exercised previously granted restricted stock units that converted into a total of 318 shares of common stock on May 22, 2026. These RSUs convert into common stock on a one-for-one basis and were granted in connection with his service on boards of wholly-owned subsidiaries.
After these routine equity compensation-related conversions, Rubin directly holds 232,656 shares of Trupanion common stock. The filing shows only derivative exercises and no open‑market purchases or sales.
Trupanion EVP Steve Weinrauch reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On May 22 and May 25, 2026, RSUs vested and converted into common stock, and the company withheld a total of 1,180 common shares at prices around $21.86–$21.98 per share to cover income tax obligations. The filing notes these tax-withholding dispositions do not represent open-market sales by Weinrauch. Across these vesting events, 4,857 RSUs converted into common stock. Following the transactions, Weinrauch holds 76,236 shares of Trupanion common stock directly.
TRUPANION, INC. Chief Financial Officer Fawwad Qureshi reported a mix of equity compensation vesting, tax withholding, and stock sales. On May 22 and May 25, 2026, he exercised restricted stock units to acquire a total of 13,744 shares of common stock at a conversion price of $0.00 per share. To cover income tax obligations tied to these vestings, the issuer withheld a total of 5,486 shares, which the filing clarifies do not represent sales by Qureshi.
On May 27, 2026, Qureshi sold an aggregate of 6,177 shares of common stock in open-market transactions at weighted average prices of about $22.63 and $22.17 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2025. Following these transactions, he directly holds 2,081 shares of common stock. The filing also shows continuing holdings of restricted stock units that convert into common stock on a one-for-one basis, including 31,047 RSUs from a prior grant.
Trupanion, Inc. Chief Legal Officer Asher Bearman reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On May 22, 2026 and May 25, 2026, RSUs converted into common stock and the company withheld shares to cover income tax obligations.
Across these transactions, Bearman acquired 2,609 shares of common stock through RSU vesting and 844 shares were withheld by the issuer to satisfy tax withholding and remittance obligations, which the filing notes does not represent a sale by the reporting person. Following the latest transaction, Bearman directly owns 72,244 shares of Trupanion common stock.
Morgan Stanley Smith Barney LLC filed a Form 144 reporting a proposed sale of 6,177 shares of common stock. The notice lists 3,340 restricted shares dated 05/22/2026 and 2,837 restricted shares dated 05/25/2026. The form lists the transaction date 05/27/2026 and identifies the securities as restricted stock.
Trupanion director Elizabeth McLaughlin received a new equity award in the form of restricted stock units. On May 11, 2026, she was granted 3,281 RSUs, each convertible into one share of Trupanion common stock.
The RSUs vest in four equal installments, with one-quarter of the units converting into common stock on each of August 22, 2026, November 22, 2026, February 22, 2027, and May 22, 2027, as long as she continues to serve through each vesting date. She has elected deferred settlement so the award will not actually settle into shares until 60 days after her death, disability, or separation from service, or immediately if there is a change of control.
TRUPANION, INC. director Bradley S. Powell reported a grant of 6,563 restricted stock units (RSUs) linked to the company’s common stock. These RSUs were awarded at no cash cost to Powell and convert into common shares on a one-for-one basis as they vest.
The RSUs vest in four equal installments: one‑quarter of the award on each of August 22, 2026, November 22, 2026, February 22, 2027, and May 22, 2027, subject to Powell’s continued service through each vesting date. After this grant, Powell’s reported RSU holdings from this award total 6,563 units.
TRUPANION, INC. director Max Broden received a grant of 6,375 restricted stock units (RSUs) on May 11, 2026. These RSUs convert into common stock on a one-for-one basis and represent his reported derivative holdings following the transaction.
The award is scheduled to vest in four equal installments, each covering 1/4 of the total shares, on August 22, 2026, November 22, 2026, February 22, 2027, and May 22, 2027, subject to his continued service. Because Broden will not stand for reelection at the 2026 Annual Meeting of Stockholders, he will vest in 1/4 of the shares immediately prior to that meeting if he remains in service, and the remaining unvested shares will be forfeited under the Non-Employee Director Compensation Program.
The reporting person has elected deferred settlement, so the vested RSUs will generally not settle into common stock until 60 days after his death, disability or separation from service, or immediately upon a change of control.
TRUPANION, INC. director Paulette R. Dodson received a grant of 4,031 restricted stock units (RSUs) on May 11, 2026 as equity compensation. These RSUs convert into common stock on a one-for-one basis.
The award vests in four equal installments, with one quarter of the RSUs scheduled to vest on each of August 22, 2026, November 22, 2026, February 22, 2027, and May 22, 2027, subject to continued service. Settlement is deferred until 60 days after Dodson’s death, disability, or separation from service, or immediately upon a change of control.